InfuSystems (INFU) vs SS Innovations International (SSII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
InfuSystems (INFU) has outperformed SS Innovations International (SSII) over the past year, gaining 51.7% versus a loss of 78.7%. InfuSystems is the larger company by market cap ($287.5 million vs $254.9 million), about 1.1 times the size, while SS Innovations International is growing revenue faster (+105.7% vs +6.4%). InfuSystems converts more of its revenue into profit, with a net margin of 4.6% versus -28.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INFU | SSII |
|---|---|---|
| Share price | $14.35 | $1.27 |
| Market cap | $287.48M | $254.86M |
| 1-day change | +2.06% | -0.78% |
| YTD return | +59.98% | -77.64% |
| 1-year return | +51.69% | -78.69% |
| 5-year return | -15.93% | — |
| P/E ratio (TTM) | 32.61 | — |
| Forward P/E | 25.63 | — |
| EPS (TTM) | $0.44 | $-0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $143.44M | $42.48M |
| Revenue growth (YoY) | +6.36% | +105.74% |
| Net income (latest FY) | $6.63M | $-12.13M |
| Gross margin | 55.98% | 46.00% |
| Operating margin | 8.31% | -19.29% |
| Net margin | 4.62% | -28.55% |
| 52-week high | $15.47 | $6.79 |
| 52-week low | $7.29 | $1.12 |
| Distance from 52-week high | -7.24% | -81.30% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +28.92% | +451.18% |
| Average volume | 136.60K | 86.18K |
| Shares outstanding | 20.03M | 200.68M |
| Employees | 461 | 483 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INFU has outperformed SSII by 130.4 percentage points over the past year.
- InfuSystems is more profitable, keeping 4.6 cents of every revenue dollar as net income versus -28.5 cents for SS Innovations International.
- SS Innovations International grew revenue faster in its latest fiscal year (+105.74% vs +6.36%).
About InfuSystems
INFU stock →InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions.
Health Care · Medical/Dental Instruments · 461 employees
About SS Innovations International
SSII stock →SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.
Health Care · Medical/Dental Instruments · 483 employees
INFU vs SSII FAQ
Which is bigger, InfuSystems or SS Innovations International?
InfuSystems (INFU) is larger, with a market capitalization of $287.48M compared with $254.86M for SS Innovations International (SSII).
Which stock has performed better over the past year, INFU or SSII?
INFU returned +51.69% over the past 12 months, compared with -78.69% for SSII (price return, excluding dividends). Past performance does not predict future results.
Are InfuSystems and SS Innovations International in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.